APA (7th ed.) Citation

GC, G., MM, T., AI, K., L, M., AD, J., LR, P., . . . LCC, L. (2026). Long-Term Protective Immune Responses Induced by rBCG-RBD/rRBD Heterologous Prime/Boost Immunization Strategy: Fusion of RBD-Wuhan with LTB Adjuvant Induces Cross-Reactivity with SARS-CoV-2 Variant Omicron. Vaccines, 14(2), . https://doi.org/10.3390/vaccines14020120

Chicago Style (17th ed.) Citation

GC, Gaboardi, et al. "Long-Term Protective Immune Responses Induced by RBCG-RBD/rRBD Heterologous Prime/Boost Immunization Strategy: Fusion of RBD-Wuhan with LTB Adjuvant Induces Cross-Reactivity with SARS-CoV-2 Variant Omicron." Vaccines 14, no. 2 (2026). https://doi.org/10.3390/vaccines14020120.

MLA (9th ed.) Citation

GC, Gaboardi, et al. "Long-Term Protective Immune Responses Induced by RBCG-RBD/rRBD Heterologous Prime/Boost Immunization Strategy: Fusion of RBD-Wuhan with LTB Adjuvant Induces Cross-Reactivity with SARS-CoV-2 Variant Omicron." Vaccines, vol. 14, no. 2, 2026, https://doi.org/10.3390/vaccines14020120.